Literature DB >> 27466428

Existence of Two Distinct Infectious Endogenous Retroviruses in Domestic Cats and Their Different Strategies for Adaptation to Transcriptional Regulation.

Kyohei Kuse1, Jumpei Ito1, Ariko Miyake1, Junna Kawasaki1, Shinya Watanabe1, Isaac Makundi2, Minh Ha Ngo2, Takeshige Otoi3, Kazuo Nishigaki4.   

Abstract

UNLABELLED: Endogenous retroviruses (ERVs) are the remnants of ancient retroviral infections of germ cells. Previous work identified one of the youngest feline ERV groups, ERV-DC, and reported that two ERV-DC loci, ERV-DC10 and ERV-DC18 (ERV-DC10/DC18), can replicate in cultured cells. Here, we identified another replication-competent provirus, ERV-DC14, on chromosome C1q32. ERV-DC14 differs from ERV-DC10/DC18 in its phylogeny, receptor usage, and, most notably, transcriptional activities; although ERV-DC14 can replicate in cultured cells, it cannot establish a persistent infection owing to its low transcriptional activity. Furthermore, we examined ERV-DC transcription and its regulation in feline tissues. Quantitative reverse transcription-PCR (RT-PCR) detected extremely low ERV-DC10 expression levels in feline tissues, and bisulfite sequencing showed that 5' long terminal repeats (LTRs) of ERV-DC10/DC18 are significantly hypermethylated in feline blood cells. Reporter assays found that the 5'-LTR promoter activities of ERV-DC10/DC18 are high, whereas that of ERV-DC14 is low. This difference in promoter activity is due to a single substitution from A to T in the LTR, and reverse mutation at this nucleotide in ERV-DC14 enhanced its replication and enabled it to persistently infect cultured cells. Therefore, ERV-DC LTRs can be divided into two types based on this nucleotide, the A type or T type, which have strong or attenuated promoter activity, respectively. Notably, ERV-DCs with T-type LTRs, such as ERV-DC14, have expanded in the cat genome significantly more than A-type ERV-DCs, despite their low promoter activities. Our results provide insights into how the host controls potentially infectious ERVs and, conversely, how ERVs adapt to and invade the host genome. IMPORTANCE: The domestic cat genome contains many endogenous retroviruses, including ERV-DCs. These ERV-DCs have been acquired through germ cell infections with exogenous retroviruses. Some of these ERV-DCs are still capable of producing infectious virions. Hosts must tightly control these ERVs because replication-competent viruses in the genome pose a risk to the host. Here, we investigated how ERV-DCs are adapted by their hosts. Replication-competent viruses with strong promoter activity, such as ERV-DC10 and ERV-DC18, were suppressed by promoter methylation in LTRs. On the other hand, replication-competent viruses with weak promoter activity, such as ERV-DC14, seemed to escape strict control via promoter methylation by the host. Interestingly, ERV-DCs with weak promoter activity, such as ERV-DC14, have expanded in the cat genome significantly more than ERV-DCs with strong promoter activity. Our results improve the understanding of the host-virus conflict and how ERVs adapt in their hosts over time.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27466428      PMCID: PMC5044828          DOI: 10.1128/JVI.00716-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  RD-114 and feline leukaemia virus genome expression in natural lymphomas of domestic cats.

Authors:  H L Niman; J R Stephenson; M B Gardner; P Roy-Burman
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

Review 3.  Fighting fire with fire: endogenous retrovirus envelopes as restriction factors.

Authors:  Ray Malfavon-Borja; Cédric Feschotte
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

4.  Characterization of a type C virus released from the porcine cell line PK(15).

Authors:  G J Todaro; R E Benveniste; M M Lieber; C J Sherr
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

5.  Recombinant origin of the retrovirus XMRV.

Authors:  Tobias Paprotka; Krista A Delviks-Frankenberry; Oya Cingöz; Anthony Martinez; Hsing-Jien Kung; Clifford G Tepper; Wei-Shau Hu; Matthew J Fivash; John M Coffin; Vinay K Pathak
Journal:  Science       Date:  2011-05-31       Impact factor: 47.728

6.  Infectious endogenous retroviruses in cats and emergence of recombinant viruses.

Authors:  Yukari Anai; Haruyo Ochi; Shinya Watanabe; So Nakagawa; Maki Kawamura; Takashi Gojobori; Kazuo Nishigaki
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

7.  Dilute (d) coat colour mutation of DBA/2J mice is associated with the site of integration of an ecotropic MuLV genome.

Authors:  N A Jenkins; N G Copeland; B A Taylor; B K Lee
Journal:  Nature       Date:  1981-10-01       Impact factor: 49.962

8.  Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.

Authors:  Jumpei Ito; Takuya Baba; Junna Kawasaki; Kazuo Nishigaki
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

9.  Positional cloning of the mouse retrovirus restriction gene Fv1.

Authors:  S Best; P Le Tissier; G Towers; J P Stoye
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

Review 10.  Retrotransposons shape species-specific embryonic stem cell gene expression.

Authors:  Luisa Robbez-Masson; Helen M Rowe
Journal:  Retrovirology       Date:  2015-05-29       Impact factor: 4.602

View more
  7 in total

1.  Medicine's movable feast: What jumping genes can teach us about treating disease.

Authors:  Roxanne Khamsi
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

2.  Tracking the Fate of Endogenous Retrovirus Segregation in Wild and Domestic Cats.

Authors:  Minh Ha Ngo; MaríaCruz Arnal; Ryosuke Sumi; Junna Kawasaki; Ariko Miyake; Chris K Grant; Takeshige Otoi; Daniel Fernández de Luco; Kazuo Nishigaki
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.

Authors:  Ariko Miyake; Junna Kawasaki; Ha Ngo; Isaac Makundi; Yutaro Muto; Arshad H Khan; Desmond J Smith; Kazuo Nishigaki
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

4.  Convergent evolution of antiviral machinery derived from endogenous retrovirus truncated envelope genes in multiple species.

Authors:  Ariko Miyake; Minh Ha Ngo; Shelly Wulandari; Masayuki Shimojima; So Nakagawa; Junna Kawasaki; Kazuo Nishigaki
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-24       Impact factor: 12.779

5.  Presence of a Shared 5'-Leader Sequence in Ancestral Human and Mammalian Retroviruses and Its Transduction into Feline Leukemia Virus.

Authors:  Junna Kawasaki; Maki Kawamura; Yoshiharu Ohsato; Jumpei Ito; Kazuo Nishigaki
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

6.  Systematic identification and characterization of regulatory elements derived from human endogenous retroviruses.

Authors:  Jumpei Ito; Ryota Sugimoto; Hirofumi Nakaoka; Shiro Yamada; Tetsuaki Kimura; Takahide Hayano; Ituro Inoue
Journal:  PLoS Genet       Date:  2017-07-12       Impact factor: 5.917

Review 7.  Tracking the Continuous Evolutionary Processes of an Endogenous Retrovirus of the Domestic Cat: ERV-DC.

Authors:  Junna Kawasaki; Kazuo Nishigaki
Journal:  Viruses       Date:  2018-04-06       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.